PFM Health Sciences’s Inhibrx INBX Stock Holding History
Bought
Maintained
Sold
Other funds holding INBX
PFM Health Sciences's INBX Position: Q3 2026 in Review
PFM Health Sciences increased its Inhibrx (INBX) stake by 3.9% in Q3 2026, buying an estimated $1.19M and bringing the position to 320,331 shares worth $32.1M. The position accounts for 3.2% of the portfolio, ranked #6.
PFM Health Sciences first reported a position in INBX in Q2 2024 and has held it in 10 quarters since. 172 funds tracked by Wall St. Rank hold INBX as of Q3 2026.
- PFM Health Sciences held 320,331 shares of Inhibrx worth $32.1M as of Q3 2026.
- PFM Health Sciences bought 11,946 Inhibrx shares in Q3 2026, an estimated $1.19M.
- Inhibrx made up 3.2% of PFM Health Sciences's portfolio in Q3 2026, its #6 holding.
- PFM Health Sciences first reported a position in Inhibrx in Q2 2024 and has held it in 10 quarters since.
- 172 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.
Based on PFM Health Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.